Sihuan Pharmaceutical Company Top Insiders
SHPHF Stock | USD 0.10 0.00 0.00% |
Sihuan Pharmaceutical employs about 3.9 K people. The company is managed by 9 executives with a total tenure of roughly 54 years, averaging almost 6.0 years of service per executive, having 432.89 employees per reported executive. Examination of Sihuan Pharmaceutical's management performance can provide insight into the company performance.
Weicheng Guo Chairman Deputy Chairman, CEO and Member of Nomination Committee |
Fengsheng Che Chairman Co-Founder, Executive Chairman and Member of Remuneration Committee |
Sihuan |
Sihuan Pharmaceutical Management Team Effectiveness
Sihuan Pharmaceutical's management efficiency ratios could be used to measure how well Sihuan Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Sihuan Pharmaceutical Workforce Comparison
Sihuan Pharmaceutical Holdings is currently regarded as top stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 4,126. Sihuan Pharmaceutical totals roughly 3,896 in number of employees claiming about 94% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Sihuan Pharmaceutical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Sihuan Pharmaceutical Price Series Summation is a cross summation of Sihuan Pharmaceutical price series and its benchmark/peer.
Sihuan Pharmaceutical Notable Stakeholders
A Sihuan Pharmaceutical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sihuan Pharmaceutical often face trade-offs trying to please all of them. Sihuan Pharmaceutical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sihuan Pharmaceutical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Weicheng Guo | Deputy Chairman, CEO and Member of Nomination Committee | Profile | |
Fengsheng Che | Co-Founder, Executive Chairman and Member of Remuneration Committee | Profile | |
Xianhui Meng | Deputy General Manager of Sales and Marketing and Executive Director | Profile | |
Jionglong Zhang | Non-Executive Director | Profile | |
Feng Guo | Executive Director | Profile | |
Yanling Chen | Joint Director | Profile | |
Guili Miao | Chief CEO | Profile | |
Kin Li | Joint Sec | Profile | |
Chengkon Shih | General Manager of Shandong Xuanzhu | Profile |
About Sihuan Pharmaceutical Management Performance
The success or failure of an entity such as Sihuan Pharmaceutical often depends on how effective the management is. Sihuan Pharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sihuan management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sihuan management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the Peoples Republic of China. The company was founded in 2001 and is based in Wanchai, Hong Kong. Sihuan Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3896 people.
Sihuan Pharmaceutical Workforce Analysis
Traditionally, organizations such as Sihuan Pharmaceutical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sihuan Pharmaceutical within its industry.Sihuan Pharmaceutical Manpower Efficiency
Return on Sihuan Pharmaceutical Manpower
Revenue Per Employee | 844.8K | |
Revenue Per Executive | 365.7M | |
Net Income Per Employee | 106.9K | |
Net Income Per Executive | 46.3M | |
Working Capital Per Employee | 1.2M | |
Working Capital Per Executive | 517.8M |
Complementary Tools for Sihuan Pink Sheet analysis
When running Sihuan Pharmaceutical's price analysis, check to measure Sihuan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sihuan Pharmaceutical is operating at the current time. Most of Sihuan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sihuan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sihuan Pharmaceutical's price. Additionally, you may evaluate how the addition of Sihuan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world |